Amedisys Valuation
| AMEDDelisted Stock | USD 100.99 0.03 0.03% |
At this time, the firm appears to be overvalued. Amedisys shows a prevailing Real Value of $84.24 per share. The current price of the firm is $100.99. Our model approximates the value of Amedisys from analyzing the firm fundamentals such as return on equity of 0.0667, and Profit Margin of 0.04 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Amedisys' price fluctuation is very steady at this time. Calculation of the real value of Amedisys is based on 3 months time horizon. Increasing Amedisys' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Amedisys stock is determined by what a typical buyer is willing to pay for full or partial control of Amedisys. Since Amedisys is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amedisys Stock. However, Amedisys' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 100.99 | Real 84.24 | Hype 100.99 |
The real value of Amedisys Stock, also known as its intrinsic value, is the underlying worth of Amedisys Company, which is reflected in its stock price. It is based on Amedisys' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Amedisys' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Amedisys helps investors to forecast how Amedisys stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amedisys more accurately as focusing exclusively on Amedisys' fundamentals will not take into account other important factors: Amedisys Total Value Analysis
Amedisys is presently forecasted to have valuation of 3.43 B with market capitalization of 3.32 B, debt of 460.18 M, and cash on hands of 17.96 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Amedisys fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.43 B | 3.32 B | 460.18 M | 17.96 M |
Amedisys Investor Information
About 96.0% of the company shares are held by institutions such as insurance companies. The book value of Amedisys was presently reported as 37.48. The company has Price/Earnings To Growth (PEG) ratio of 1.47. Amedisys had not issued any dividends in recent years. The entity had 4:3 split on the 5th of December 2006. Based on the key indicators related to Amedisys' liquidity, profitability, solvency, and operating efficiency, Amedisys is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Amedisys Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Amedisys has an asset utilization ratio of 109.8 percent. This indicates that the Company is making $1.1 for each dollar of assets. An increasing asset utilization means that Amedisys is more efficient with each dollar of assets it utilizes for everyday operations.Amedisys Ownership Allocation
Amedisys holds a total of 32.89 Million outstanding shares. The majority of Amedisys outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Amedisys to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Amedisys. Please pay attention to any change in the institutional holdings of Amedisys as this could imply that something significant has changed or is about to change at the company. On September 15, 2025, Representative Lisa McClain of US Congress acquired under $15k worth of Amedisys's common stock.Amedisys Profitability Analysis
The company reported the previous year's revenue of 2.35 B. Net Income was 38.16 M with profit before overhead, payroll, taxes, and interest of 1.04 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Amedisys' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Amedisys and how it compares across the competition.
About Amedisys Valuation
The delisted stock valuation mechanism determines Amedisys' current worth on a weekly basis. Our valuation model uses a comparative analysis of Amedisys. We calculate exposure to Amedisys's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Amedisys's related companies.Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana. Amedisys operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 21000 people.
Amedisys Growth Indicators
Investing in growth stocks can be very risky. If the company such as Amedisys does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 33.1 M | |
| Quarterly Earnings Growth Y O Y | -0.143 | |
| Forward Price Earnings | 22.0264 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in world development indicators. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Amedisys Stock
If you are still planning to invest in Amedisys check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amedisys' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |